What's the latest on the injectable that Charlie Sheen is bragging about in Variety?


Cytodyn is enrolling two studies right now using their once per week CCR5 inhibitor injection.

One of the studies is looking for patients who have a viral load and who have HIV that has developed resistance to 3 drug classes. They will start PRO-140 plus two new medications to which their virus is susceptible. Patients have to have a R5 tropic virus.

The other study is looking for people who patients with undetectable viral load who want to stop their daily oral medications to switch to their weekly injection as monotherapy.

You can find more information about how to enroll here

A Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination w/ Optimized Background Therapy in Treatment-Experienced HIV Subjects (PRO 140)

More information about this drug

An Overview of PRO-140

Stay tuned for more information!


Nelson Vergel